Human Immunoglobulin Antistaphylococcal Donor

Human anti-staphylococcal donor immunoglobulin: description, composition, indications for use and contraindications

Human anti-staphylococcal immunoglobulin donor is a drug that is used to treat staphylococcal infections. The drug is produced in Russia at the Gabrichevsky Plant for the Production of Bacterial Preparations and belongs to the group of immunoglobulins.

The composition of the drug includes at least 100 IU of antialphastaphylolysine in one dose of liquid solution for injection. Antialphastaphylolysin is an antibody that neutralizes the harmful effects of staphylococcal toxin.

Indications for the use of human anti-staphylococcal donor immunoglobulin are associated with the treatment of staphylococcal infections such as sepsis, pneumonia, osteomyelitis, skin and soft tissue infections and others.

Contraindications to the use of the drug include hypersensitivity to its components. When using human anti-staphylococcal donor immunoglobulin, side effects may be observed, such as hyperemia at the injection site, fever, and allergic reactions.

There is no data on the interaction of the drug with other drugs. There is also no data on overdose.

After the administration of human antistaphylococcal immunoglobulin donor, it is necessary to monitor the patient for 30 minutes due to the possibility of developing allergic reactions. When using the drug, antishock therapy should be prepared. The drug is not suitable for use in ampoules with damaged integrity and labeling, changes in physical properties (turbidity, intense coloring, presence of unbreakable flakes), expired expiration dates, or improper storage.

Human anti-staphylococcal immunoglobulin donor was registered in Russia in 1996 and is an effective drug for the treatment of staphylococcal infections. However, its use should only be carried out under the supervision of qualified medical personnel.